Quantcast

Myo-T12 Available to Consumers on RonnieColemanNutrition.com

August 9, 2011

Atlas Therapeutics is pleased to announce that its revolutionary weight-training supplement, Myo-T12, is now available for purchase on RonnieColemanNutrition.com.

Delray Beach, FL (PRWEB) August 08, 2011

Atlas Therapeutics is pleased to announce that its revolutionary weight-training supplement, Myo-T12, is now available for purchase on RonnieColemanNutrition.com.

Myo-T12, which is the world’s first clinically validated myostatin inhibitor, provides a better and healthier way for everyday athletes to increase strength and build muscle mass.

“We are very happy to announce that Myo-T12 will now be available on RonnieColemanNutrition.com,” said Wayne Gretzky, hockey legend and spokesperson for Myo-T12. “This brand has already had a major impact on the fitness and body building industry, and this expansion will only further its scope with consumers across the globe.”

Myo-T12 works by modulating the body’s levels of myostatin, a genetic protein that restricts muscle growth no matter how hard a person trains and lifts weights. It has been clinically proven to reduce the average serum myostatin levels in the body by up to 46 percent within 12-18 hours, after just a single serving.

RonnieColemanNutrition.com features over 170 name-brand supplements and thousands of sports nutrition products for body builders, athletes and those who simply want to get in better shape and build muscle. The company was started by Ronnie Coleman, the eight-time winner of the Mr. Olympia body building competition and spokesperson for numerous supplements around the world.

“We are very excited to work with Atlas Therapeutics in carrying Myo-T12 on RonnieColemanNutrition.com,” Coleman said. “These types of outstanding and innovative products are what we are all about, and this represents a great partnership.”

Myo-T12 is backed by innovative research that has found ways to modulate the body’s production of myostatin. The technology behind it includes a sophisticated, multi-step handling process that maximizes ingredient stability and optimizes biological activity.

“The sports nutrition industry has waited years for a supplement that could effectively inhibit myostatin like Myo-T12 does,” said Mitch Gould, President of Ronnie Coleman Nutrition. “This is a big step forward for both of our companies.”

To learn more about Myo-T12, visit http://www.myoT12.com.

###

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2011/8/prweb8698025.htm


Source: prweb



comments powered by Disqus